BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37797754)

  • 21. Cytomorphology of papillary renal neoplasm with reverse polarity.
    Satturwar S; Parwani AV
    Cytojournal; 2023; 20():43. PubMed ID: 38053633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary Renal Neoplasm With Reverse Polarity: A Morphologic, Immunohistochemical, and Molecular Study.
    Al-Obaidy KI; Eble JN; Cheng L; Williamson SR; Sakr WA; Gupta N; Idrees MT; Grignon DJ
    Am J Surg Pathol; 2019 Aug; 43(8):1099-1111. PubMed ID: 31135486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Papillary Renal Neoplasm With Reverse Polarity: A Clinicopathologic Study of 7 Cases.
    Zhou L; Xu J; Wang S; Yang X; Li C; Zhou J; Zhang P; Xu H; Wang C
    Int J Surg Pathol; 2020 Oct; 28(7):728-734. PubMed ID: 32403965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary renal neoplasm with reverse polarity with a favorable prognosis: Two cases report and literature review.
    Yuzhi Z; Zhen L; Yu X; Boju P; Weigang Y; Xingcheng W
    Front Oncol; 2022; 12():1011422. PubMed ID: 36387104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary renal neoplasm with reverse polarity: A case report.
    Xing C; Tian H; Zhang Y; Zhang L; Kong J
    Front Oncol; 2023; 13():1072213. PubMed ID: 37143937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare papillary renal neoplasm with reverse polarity: A case report and review of the literature.
    Tu X; Zhuang X; Chen Q; Wang W; Huang C
    Front Oncol; 2023; 13():1101268. PubMed ID: 37007143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA3 aids in distinguishing fumarate hydratase-deficient renal cell carcinoma from papillary renal cell carcinoma.
    Liu Y; Dong Y; Gu Y; Xu H; Fan Y; Li X; Dong L; Zhou L; Yang X; Wang C
    Ann Diagn Pathol; 2022 Oct; 60():152007. PubMed ID: 35841867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncocytic papillary renal cell carcinoma: A clinicopathological and genetic analysis and indolent clinical course in 14 cases.
    Han G; Yu W; Chu J; Liu Y; Jiang Y; Li Y; Zhang W
    Pathol Res Pract; 2017 Jan; 213(1):1-6. PubMed ID: 27931799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases.
    Rogala J; Kojima F; Alaghehbandan R; Agaimy A; Martinek P; Ondic O; Ulamec M; Sperga M; Michalova K; Pivovarcikova K; Pitra T; Hora M; Ferak I; Marečková J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151441. PubMed ID: 31862520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
    Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
    Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 34. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
    Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
    Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.
    Xia QY; Rao Q; Shen Q; Shi SS; Li L; Liu B; Zhang J; Wang YF; Shi QL; Wang JD; Ma HH; Lu ZF; Yu B; Zhang RS; Zhou XJ
    Int J Clin Exp Pathol; 2013; 6(7):1392-9. PubMed ID: 23826421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21).
    Argani P; Antonescu CR; Couturier J; Fournet JC; Sciot R; Debiec-Rychter M; Hutchinson B; Reuter VE; Boccon-Gibod L; Timmons C; Hafez N; Ladanyi M
    Am J Surg Pathol; 2002 Dec; 26(12):1553-66. PubMed ID: 12459622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncocytic papillary renal cell carcinoma: a clinicopathological analysis of nineteen cases].
    Zhang W; Zhang LX; Yang T; Zou YW; Liu XL; Yu WJ; Jiang YX; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):981-986. PubMed ID: 36207910
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acquired cystic kidney disease-associated renal cell carcinoma: a clinicopathologic study of three cases].
    Zhang W; Xu LL; Yu WJ; Wang Q; Jiang YX; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):366-371. PubMed ID: 29783804
    [No Abstract]   [Full Text] [Related]  

  • 40. "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
    Pivovarcikova K; Peckova K; Martinek P; Montiel DP; Kalusova K; Pitra T; Hora M; Skenderi F; Ulamec M; Daum O; Rotterova P; Ondic O; Dubova M; Curik R; Dunatov A; Svoboda T; Michal M; Hes O
    Virchows Arch; 2016 Jul; 469(1):71-80. PubMed ID: 27072821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.